Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Clinical trial NCT05667649 · RECRUITING
Trial details
- NCT number
- NCT05667649
- Sponsor
- Regeneration Biomedical, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2026-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.